Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Aepfelbacher M et al. Cholesterol modulates PAF-stimulated Ca2(+)-mobilization in monocytic U937 cells. 1991 Biochim. Biophys. Acta pmid:2043662
Maziere C et al. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells. 1994 Biochim. Biophys. Acta pmid:8280775
Kern H et al. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. 1998 Biochim. Biophys. Acta pmid:9767093
Qu XW et al. Type I nitric oxide synthase (NOS) is the predominant NOS in rat small intestine. Regulation by platelet-activating factor. 1999 Biochim. Biophys. Acta pmid:10446403
Roy Baker R and Chang Hy MgATP may depress de novo neuronal nuclear PAF generation by promoting the formation of alkylacylglycerophosphate, an inhibitor of alkylglycerophosphate acetyltransferase. 2002 Biochim. Biophys. Acta pmid:12457714
Baker PR et al. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. 2002 Biochim. Biophys. Acta pmid:12379481
Nakayama R et al. Effect of 17 beta-estradiol on PAF and prostaglandin levels in oophorectomized rat uterus. 1991 Biochim. Biophys. Acta pmid:1892893
Jehle R et al. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. 2001 Biochim. Biophys. Acta pmid:11420174
Kawasaki T and Snyder F The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla. 1987 Biochim. Biophys. Acta pmid:3036238
Shukla SD et al. Activation of phospholipase C in platelets by platelet activating factor and thrombin causes hydrolysis of a common pool of phosphatidylinositol 4,5-bisphosphate. 1987 Biochim. Biophys. Acta pmid:3036249
Drapier JC et al. Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulants. 1983 Biochim. Biophys. Acta pmid:6131693
Testet-Lamant V et al. Enzymatic synthesis of structural analogs of PAF-acether by phospholipase D-catalysed transphosphatidylation. 1992 Biochim. Biophys. Acta pmid:1536875
Dumas E et al. Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor. 2012 Biochim. Biophys. Acta pmid:22198097
Snyder F The ether lipid trail: a historical perspective. 1999 Biochim. Biophys. Acta pmid:9989259
Svetlov SI et al. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. 1997 Biochim. Biophys. Acta pmid:9219895
Ninio E et al. Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. 1982 Biochim. Biophys. Acta pmid:7055592
Newman GE et al. Utilization by human amniocytes for prostaglandin synthesis of [1-14C]arachidonate derived from 2-[1-14C]arachidonylphosphatidylcholine associated with human fetal pulmonary surfactant. 1993 Biochim. Biophys. Acta pmid:8452866
Hopkins NK et al. Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4. 1983 Biochim. Biophys. Acta pmid:6313071
Winkler JD et al. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. 1997 Biochim. Biophys. Acta pmid:9219900
Clay KL et al. Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells. 1991 Biochim. Biophys. Acta pmid:1909182
McCall MR et al. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. 1999 Biochim. Biophys. Acta pmid:9931415
Triggiani M and Chilton FH Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 1989 Biochim. Biophys. Acta pmid:2572273
Dupuis F et al. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. 1997 Biochim. Biophys. Acta pmid:9434130
Triggiani M et al. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 1991 Biochim. Biophys. Acta pmid:1647203
Wang MM et al. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability. 1999 Biochim. Biophys. Acta pmid:9989266
Nijssen JG et al. Identification of a calcium-independent phospholipase A2 in rat lung cytosol and differentiation from acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF-acether). 1986 Biochim. Biophys. Acta pmid:3707986
Kloprogge E et al. Stimulus-aggregation coupling in platelets activated with PAF-acether. 1986 Biochim. Biophys. Acta pmid:3089297
Nishihira J et al. A role for oxygen radicals in rat monocytic leukemia cell differentiation under stimulation with platelet-activating factor. 1994 Biochim. Biophys. Acta pmid:8305501
Alam I and Silver MJ Acetyltransferase activity in human platelet microsomes and washed platelets. 1986 Biochim. Biophys. Acta pmid:3094588
Piéroni G and Hanahan DJ Effect of acetylglyceryl ether phosphocholine (platelet-activating factor) and thrombin on acylation of exogenous lysophosphoglycerides in rabbit platelets. 1986 Biochim. Biophys. Acta pmid:3719000
Lauener RW et al. A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin. 1999 Biochim. Biophys. Acta pmid:10559473
Gora S et al. The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2. 2006 Biochim. Biophys. Acta pmid:16962371
Blank ML et al. Characterization of the enzymatic hydrolysis of acetate from alkylacetylglycerols in the de novo pathway of PAF biosynthesis. 1990 Biochim. Biophys. Acta pmid:2302414
Travers JB et al. The metabolism of platelet-activating factor in human T-lymphocytes. 1990 Biochim. Biophys. Acta pmid:2302420
Fauler J et al. Platelet-activating factor induces the production of leukotrienes by human monocytes. 1989 Biochim. Biophys. Acta pmid:2790041
Clark PO et al. Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. 1980 Biochim. Biophys. Acta pmid:7357030
Samples BL et al. Subcellular localization of enzyme activities involved in the metabolism of platelet-activating factor in rainbow trout leukocytes. 1999 Biochim. Biophys. Acta pmid:10101269
Banks JB et al. Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol. 1988 Biochim. Biophys. Acta pmid:3382692
Bette-Bobillo P et al. Interaction between blood components and a spin-labeled analogue of PAF-acether. 1986 Biochim. Biophys. Acta pmid:3017416
De Plaen IG et al. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. 1998 Biochim. Biophys. Acta pmid:9630621
Rao GH et al. Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. 1982 Biochim. Biophys. Acta pmid:6280777
Montero M et al. Comparative effects of cytochrome P-450 inhibitors on Ca2+ and Mn2+ entry induced by agonists or by emptying the Ca2+ stores of human neutrophils. 1993 Biochim. Biophys. Acta pmid:7684611
Ninio E et al. Biosynthesis of paf-acether. XI. Regulation of acetyltransferase by enzyme-substrate imbalance. 1988 Biochim. Biophys. Acta pmid:3196734
Kumar R et al. Production and effects of platelet-activating factor in the rat brain. 1988 Biochim. Biophys. Acta pmid:3196741
Nakayama R et al. Evidence for production of platelet-activating factor by yeast Saccharomyces cerevisiae cells. 1994 Biochim. Biophys. Acta pmid:8123662
Blank ML et al. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells. 1986 Biochim. Biophys. Acta pmid:3707974
Alonso MT et al. Effects of the antithrombitic agent PCA 4230 on agonist-induced Ca2+ entry and Ca2+ release in human platelets. 1992 Biochim. Biophys. Acta pmid:1312357
Caplan MS et al. Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells. 1992 Biochim. Biophys. Acta pmid:1420292
Williams KA and Haslam RJ Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor). 1984 Biochim. Biophys. Acta pmid:6696908
Albert DH and Snyder F Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages. 1984 Biochim. Biophys. Acta pmid:6435681
Teng CM et al. Antiplatelet effect of butylidenephthalide. 1987 Biochim. Biophys. Acta pmid:3109495
Karpouza AP and Vakirtzi-Lemonias C The platelet-activating factor acetylhydrolase of mouse platelets. 1997 Biochim. Biophys. Acta pmid:9030208
Bonaccorsi L et al. Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. 1997 Biochim. Biophys. Acta pmid:9042336
Rabovsky J et al. Cytochrome P-450-dependent metabolism in alveolar type II epithelial cells: modulation by platelet-activating factor. 1991 Biochim. Biophys. Acta pmid:1958697
Kimura Y et al. Effects of baicalein on leukotriene biosynthesis and degranulation in human polymorphonuclear leukocytes. 1987 Biochim. Biophys. Acta pmid:2825795
El Tamer A et al. Studies on ether phospholipids. I. A new method of determination using phospholipase A1 from guinea pig pancreas: application to Krebs II ascites cells. 1984 Biochim. Biophys. Acta pmid:6712966
Krump E and Borgeat P Kinetics of 5-lipoxygenase activation, arachidonic acid release, and leukotriene synthesis in human neutrophils: effects of granulocyte-macrophage colony-stimulating factor. 1994 Biochim. Biophys. Acta pmid:8025123
Robinson M and Snyder F Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species. 1985 Biochim. Biophys. Acta pmid:4052436
Nixon AB et al. Comparison of acceptor and donor substrates in the CoA-independent transacylase reaction in human neutrophils. 1996 Biochim. Biophys. Acta pmid:8679683
Dentan C et al. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase. 1996 Biochim. Biophys. Acta pmid:8597590
Kramer RM et al. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. 1988 Biochim. Biophys. Acta pmid:3355850
Chepenik KP and Wykle RL Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells. 1992 Biochim. Biophys. Acta pmid:1627622
Gandhi CR et al. Platelet-activating factor-mediated synthesis of prostaglandins in rat Kupffer cells. 1992 Biochim. Biophys. Acta pmid:1322709
Nakagawa Y et al. Possible influence of lysophospholipase on the production of 1-acyl-2-acetylglycerophosphocholine in macrophages. 1992 Biochim. Biophys. Acta pmid:1637856
Kitagawa S et al. Inhibitory effects of phenol derivatives on bovine platelet aggregation and their effects on Ca2+ mobilization. 1989 Biochim. Biophys. Acta pmid:2493810
Lumb RH et al. Spontaneous and protein-catalyzed transfer of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) between phospholipid bilayers. 1983 Biochim. Biophys. Acta pmid:6860678
Dupuis F et al. PAF and haematopoiesis. X. Macrophage colony-stimulating factor and granulocyte macrophage colony-stimulating factor enhance platelet-activating factor acetylhydrolase production by human blood-derived macrophages. 1996 Biochim. Biophys. Acta pmid:8603099
Fragopoulou E et al. Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties. 2003 Biochim. Biophys. Acta pmid:12782155
Woodard DS et al. Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride. 1995 Biochim. Biophys. Acta pmid:7488633
Tsoukatos DC et al. Studies on the subcellular distribution of 1-O-alkyl-2-acetyl-sn-glycero phosphocholine (PAF) and on the enzymic activities involved in its biosynthesis within the ciliate Tetrahymena pyriformis. 1993 Biochim. Biophys. Acta pmid:8218344
Hoffman DR et al. Metabolism and function of platelet-activating factor in fetal rabbit lung development. 1986 Biochim. Biophys. Acta pmid:3768390
Roy Baker R and Chang H Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors. 1998 Biochim. Biophys. Acta pmid:9507140
Rosenthal MD and Franson RC Oligomers of prostaglandin B1 inhibit arachidonic acid mobilization in human neutrophils and endothelial cells. 1989 Biochim. Biophys. Acta pmid:2557075
Samiei M et al. Activation of myelin basic protein and S6 peptide kinases in phorbol ester- and PAF-treated sheep platelets. 1993 Biochim. Biophys. Acta pmid:8385998
Tanaka T et al. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group. 1994 Biochim. Biophys. Acta pmid:8280771
van den Bosch H et al. Ether lipid synthesis and its deficiency in peroxisomal disorders. 1993 Biochimie pmid:8507680
Tencé V et al. Release, purification, and characterization of platelet-activating factor (PAF). 1980 Biochimie pmid:17941181
Watschinger K and Werner ER Orphan enzymes in ether lipid metabolism. 2013 Biochimie pmid:22771767
Olivier JL et al. Influence of PAF-acether on lecithin-oriented multibilayers monitored by ESR: interaction of PAF-acether with cholesterol. 1989 Biochimie pmid:2541796
Murakami M and Lambeau G Emerging roles of secreted phospholipase A(2) enzymes: an update. 2013 Biochimie pmid:23022039
Nankar SA et al. Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs. 2013 Biochimie pmid:23376877
Yost CC et al. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. 2010 Biochimie pmid:20167241
Tokumura A et al. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. 2000 Biofactors pmid:11237195
Grambow E et al. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity. 2016 Biofactors pmid:27151562
Yoshikawa T et al. alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. 1998 Biofactors pmid:9523024
Zinchenko VP et al. [Effect of structural analogs of platelet activating factor on the intracellular signal transduction in murine peritoneal neutrophils and macrophages of P388D1 line]. 1997 Sep-Oct Biofizika pmid:9410037
Negresku EV et al. [Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+]. 1989 Biokhimiia pmid:2551395
Kuznetsova TI and Kulikov VI [The effect of aldehydogenic and acyl structural analogs of platelet activating factor on the formation of superoxide radicals by human blood leukocytes]. 1992 Biokhimiia pmid:1327185
Kulikov VI and Bergel'son LD [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes]. 1984 Biokhimiia pmid:6093897
Kulikov VI et al. [Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. 1984 Biokhimiia pmid:6542803
Muzia GI et al. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells]. 1994 Biokhimiia pmid:7948414
Lichko LP et al. [The effect of PAF, sphingosine and heparin on certain phosphohydrolase and transport activity of yeast vacuoles]. 1994 Biokhimiia pmid:7948417
Kulikov VI and Muzia GI [Biological role of cellular metabolites--structural analogs of platelet activating factor]. 1996 Biokhimiia pmid:8724598
Muzia GI and Kulikov VI [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets]. 1996 Biokhimiia pmid:8724603
Kulikov VI and Muzia GI [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators]. 1992 Biokhimiia pmid:1420585
Muzia TI and Kulikov VN [1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine: acetylhydrolase is associated primarily with low density lipoproteins in human blood]. 1991 Biokhimiia pmid:1932343
Muzia GI et al. [Interaction of cells from murine organs with liposomes of various composition]. 1991 Biokhimiia pmid:1932348
Orlov SM et al. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs]. 1985 Biokhimiia pmid:2408682
Avdonin PV and Altukhova IP [Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels]. 1985 Biokhimiia pmid:2416359
Avdonin PV et al. [Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. 1985 Biokhimiia pmid:3000463